To elucidate the character and magnitude of the hepatitis C virus (HCV) epidemic among drug users in Amsterdam, 197 young drug users from the period 2000 to 2004 were compared with 215 counterparts from 1985 to 1989. Although injection risk behavior and HCV seroprevalence decreased sharply over time
An outbreak of hepatitis A among homeless drug users in Rotterdam, The Netherlands
✍ Scribed by G.M.S. Tjon; H. Götz; A.G. Koek; O. de Zwart; P.L.J.M. Mertens; R.A. Coutinho; S.M. Bruisten
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 210 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
From the end of January to mid‐June 2004 (weeks 5–24) a hepatitis A virus (HAV) outbreak occurred among a homeless and drug user community in Rotterdam, The Netherlands. To prevent further spread of the virus within this group and to the general population, the Municipal Health Service of Rotterdam organized a mass vaccination campaign during which 83% (1,515/1,800) of the homeless people were vaccinated. As part of a national HAV typing study, blood and/or fecal samples of 30 Rotterdam HAV IgM(+) patients who fell ill during the period of 1 September 2003–1 December 2004 were tested. The tests included RT‐PCR and sequencing at the VP3‐VP1 and VP1‐P2a regions of the HAV genome. It was found that 12 homeless people, one family member of a homeless person and two people without a known risk were infected with a unique subtype 3a strain. Four of the homeless patients became ill after vaccination and were probably infected at the time. This study shows that Dutch homeless people and drug users involved in HAV outbreaks should be offered HAV vaccine actively to prevent further spread of the infection. Furthermore, it was shown by molecular techniques that the unique subtype 3a strain was not found before the Rotterdam outbreak or afterwards, indicating that the mass vaccination campaign was successful. J. Med. Virol. 77:360–366, 2005. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Quantitative estimates of the current and future burden of hepatitis C virus (HCV) disease are required to plan a public health response to the HCV epidemic with regard to both prevention and treatment. A forward projection model was used to estimate the numbers of both current and former injecting
## Abstract From December 1977 until April 1978 a hepatitis A outbreak occurred in an institution for the mentally retarded. The institution housed 311 residents and had a staff of 308. The outbreak was studied by enzyme‐linked immunosorbent assays for hepatitis A antigen and antibodies, and by liv
The prevalence of human T-cell leukaemia virus-I and -II infection was studied in a cohort of 346 intravenous and nonintravenous drug users in Amsterdam. Three participants (0.86%) had antibodies to HTLV-I by two commercially available HTLV-I enzyme immunoassays (EIA). Infection in these three subje
## Abstract In general, little is known about the incidence of hepatitis B virus (HBV) among drug users, especially among non‐injecting drug users. Therefore, changes in incidence, risk factors, and circulating genotypes over time were determined among drug users in Amsterdam over an 18‐year period